Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 312K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hsieh, F. H. Articles by Boyce, J. A. Search for Related Content PubMed PubMed Citation Articles by Hsieh, F. H. Articles by Boyce, J. A. Social Bookmarking                            What's this?

Original Article

Fred H. Hsieh^a,c, Bing K. Lam^a,c, John F. Penrose^a,c, K. Frank Austen^a,c,d, and Joshua A. Boyce^a,b,c,d

^a Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
^b Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115
^c Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts 02115
^d Partners' Asthma Center, Boston, Massachusetts 02115
Smith 616, Brigham and Women's Hospital, 1 Jimmy Fund Way, Boston, MA 02115.617-525-1242617-525-1233

jboyce{at}rics.bwh.harvard.edu

Human mast cells (hMCs) derived in vitro from cord blood mononuclear cells exhibit stem cell factor (SCF)-dependent comitogenic responses to T helper cell type 2 (Th2) cytokines. As cysteinyl leukotriene (cys-LT) biosynthesis is a characteristic of immunoglobulin (Ig)E-activated mucosal hMCs, we speculated that Th2 cytokines might regulate eicosanoid generation by hMCs. After passive sensitization for 5 d with IgE in the presence of SCF, anti-IgE–stimulated hMCs elaborated minimal cys-LT (0.1 ± 0.1 ng/10⁶ hMCs) and abundant prostaglandin (PG)D₂ (16.2 ± 10.3 ng/10⁶ hMCs). Priming of hMCs by interleukin (IL)-4 with SCF during passive sensitization enhanced their anti-IgE–dependent histamine exocytosis and increased their generation of both cys-LT (by 27-fold) and PGD₂ (by 2.5-fold). Although priming with IL-3 or IL-5 alone for 5 d with SCF minimally enhanced anti-IgE–mediated cys-LT generation, these cytokines induced further six- and fourfold increases, respectively, in IgE-dependent cys-LT generation when provided with IL-4 and SCF; this occurred without changes in PGD₂ generation or histamine exocytosis relative to hMCs primed with IL-4 alone. None of these cytokines, either alone or in combination, substantially altered the levels of cytosolic phospholipase A₂ (cPLA₂), 5-lipoxygenase (5-LO), or 5-LO activating protein (FLAP) protein expression by hMCs. In contrast, IL-4 priming dramatically induced the steady-state expression of leukotriene C₄ synthase (LTC₄S) mRNA within 6 h, and increased the expression of LTC₄S protein and functional activity in a dose- and time-dependent manner, with plateaus at 10 ng/ml and 5 d, respectively. Priming by either IL-3 or IL-5, with or without IL-4, supported the localization of 5-LO to the nucleus of hMCs. Thus, different Th2-derived cytokines target distinct steps in the 5-LO/LTC₄S biosynthetic pathway (induction of LTC₄S expression and nuclear import of 5-LO, respectively), each of which is necessary for a full integrated functional response to IgE-dependent activation, thus modulating the effector phenotype of mature hMCs.

Key Words: eicosanoids • asthma • allergy • prostaglandin D₂ • FcRI

Abbreviations used in this paper: BMMC, bone marrow–derived MC; cPLA₂, cytosolic phospholipase A₂; cys-LT, cysteinyl leukotriene; FcRI, high-affinity Fc receptor for IgE; FLAP, 5-LO activating protein; hMC, human MC; 5-LO, 5-lipoxygenase; LT, leukotriene; LTC₄S, LTC₄ synthase; MC, mast cell; PGD₂S, PGD₂ synthase; PGHS, prostaglandin endoperoxide H synthase; RP, reverse phase; SCF, stem cell factor.

© 2001 The Rockefeller University Press

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS